Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

49.8K
Overview
49.8K
Cancer Vaccines01:30

Cancer Vaccines

764
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
764
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking the Efflux Barrier: P-Glycoprotein and Emerging Strategies to Overcome Multidrug Resistance in Cancer.

Cancers·2026
Same author

MicroRNA profiles in multiple sclerosis: A review of the literature.

Journal of neuroimmunology·2026
Same author

Real-world experience of cladribine treatment in relapsing multiple sclerosis: A Romanian multicenter nationwide study.

Multiple sclerosis and related disorders·2026
Same author

Multidisciplinary Management of an Atypical Gigantic Sciatic Nerve Schwannoma: Case Presentation and Systematic Review.

NeuroSci·2025
Same author

Immunogenetics of Multiple Sclerosis in Romanian Patients: Preliminary Data.

International journal of molecular sciences·2025
Same author

Control of type 2 diabetes in patients with cancer and chronic pro-inflammatory cytokines during the COVID-19 pandemic.

Journal of medicine and life·2025

Related Experiment Video

Updated: Dec 2, 2025

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

4.2K

Vaccination in multiple sclerosis - Challenging practices (Review).

Carmen Adella Sirbu1,2, Anca Alexandra Florea2, Minerva Claudia Ghinescu1

  • 1Department of Medical-Surgical and Prophylactical Disciplines, Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania.

Experimental and Therapeutic Medicine
|November 5, 2020
PubMed
Summary

Vaccinations are generally safe for multiple sclerosis (MS) patients, but live vaccines are contraindicated for those on immunosuppressive therapy or with allergies. Guidelines clarify vaccination recommendations for MS patients, especially those undergoing treatment.

Keywords:
disease modifying treatmentinfectionmultiple sclerosissafetyvaccination

More Related Videos

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.2K

Related Experiment Videos

Last Updated: Dec 2, 2025

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
05:44

A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis

Published on: December 9, 2022

4.2K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.2K

Area of Science:

  • Neurology
  • Immunology
  • Infectious Disease Prevention

Background:

  • Infections pose risks for multiple sclerosis (MS) patients, potentially triggering relapses and neurological decline.
  • While MS is considered an autoimmune inflammatory disease, the theory of infection as a cause is not supported by current research.
  • Vaccination is a critical preventive measure against infections but faces public and patient hesitancy.

Purpose of the Study:

  • To clarify vaccination recommendations for patients with multiple sclerosis (MS).
  • To address concerns regarding vaccine safety and efficacy in the MS population.
  • To provide guidance on timing of vaccinations, particularly live vaccines, in relation to MS treatments.

Main Methods:

  • Review of current scientific literature and clinical guidelines on vaccinations in MS patients.
  • Analysis of contraindications and precautions for vaccine administration in individuals with MS.
  • Consideration of the impact of immunosuppressive therapies on vaccine recommendations.

Main Results:

  • Vaccines are generally considered safe for the majority of MS patients.
  • Contraindications include a history of allergic reactions to vaccine components and immunosuppression (especially for live vaccines).
  • Live vaccines should ideally be administered before initiating immunosuppressive MS treatments.

Conclusions:

  • Current guidelines offer clearer recommendations for vaccinating MS patients, including those on treatment.
  • Adherence to guidelines ensures optimal infection prevention while minimizing risks associated with vaccinations in MS.
  • Informed vaccination decisions are crucial for managing MS and preventing infection-related complications.